APT Medical (SHSE:688617) FCF Margin % : -1.94% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is APT Medical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. APT Medical's Free Cash Flow for the three months ended in Mar. 2024 was ¥-9 Mil. APT Medical's Revenue for the three months ended in Mar. 2024 was ¥455 Mil. Therefore, APT Medical's FCF Margin % for the quarter that ended in Mar. 2024 was -1.94%.

As of today, APT Medical's current FCF Yield % is 1.28%.

The historical rank and industry rank for APT Medical's FCF Margin % or its related term are showing as below:

SHSE:688617' s FCF Margin % Range Over the Past 10 Years
Min: -8.06 Med: 1.69 Max: 29.51
Current: 22.13

During the past 7 years, the highest FCF Margin % of APT Medical was 29.51%. The lowest was -8.06%. And the median was 1.69%.

SHSE:688617's FCF Margin % is ranked better than
93.95% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.09 vs SHSE:688617: 22.13

APT Medical FCF Margin % Historical Data

The historical data trend for APT Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical FCF Margin % Chart

APT Medical Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-3.14

21.70

1.69

18.44

29.51

APT Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															25.64	36.19	23.53	31.74	-1.94

Competitive Comparison of APT Medical's FCF Margin %

For the Medical Devices subindustry, APT Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

APT Medical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where APT Medical's FCF Margin % falls into.

APT Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

APT Medical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	487.029	/	1650.212
	=	29.51 %

APT Medical's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-8.814	/	455.327
	=	-1.94 %

APT Medical FCF Margin % Related Terms

Thank you for viewing the detailed overview of APT Medical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

APT Medical (SHSE:688617) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000

Website

http://www.aptmed.com

APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.

Executives

Dai Zhen Hua	Directors, senior managers
Cheng Zheng Hui	Directors, senior managers
Zhang Yong	Core technical personnel
Liu Fang Yuan	senior management
Wang Wei	senior management
	Senior management, core technical personnel
Xu Yi Qing	Directors, senior managers
Han Yong Gui	Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines